CXCL9 and neoplasm: Interferon (IFN)-induced CXCR3 ligands, CXCL9/10/11, regulate tumor angiogenesis, enhance T cell infiltration, and further position activated T cells near antigen-presenting cells within the TME, which may provide additional cues to T cells that facilitate antitumor immunity (82).